Ana González-Cordón

13PUBLICATIONS
50CO-AUTHORS
Equity and trusts lawNanotoxicology, health and safetyBehavioural epidemiologyNutritional epidemiologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 11, 2026
Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study.

|May 07, 2026
Atypical HBV Serological Patterns After Switching to CAB/RPV: Interpretation Within Current Definitions.

|Apr 02, 2026
Optimizing HBV Prevention When Switching to Long-Acting Cabotegravir/Rilpivirine.

Alberto Foncillas, Juan Ambrosioni, Lorena de la Mora

|Feb 12, 2026
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension study.

Beatriz Borjabad, Jhon Rojas, Alexy Inciarte

|Jan 15, 2026
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.

Alberto Foncillas, Juan Ambrosioni, Abiu Sempere

|Dec 24, 2025
Incidence, Clinical Features and Vaccination Coverage of Pneumococcal Disease in People Living with HIV: A Retrospective Cohort Study (2015-2024).

Pere Medina, Elisa de Lazzari, Mateu Espasa

Pageof 3

Frequent Collaborators

7 joint publications

Elisa de Lazzari

7 joint publications

Berta Torres

7 joint publications

Esteban Martínez

7 joint publications

Alberto Foncillas